MAA
Managed Account Advisors Portfolio holdings
AUM
$121B
This Quarter Return
+0.07%
1 Year Return
+7.32%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$89.7B
AUM Growth
+$89.7B
(+7.8%)
Cap. Flow
+$7.24B
Cap. Flow
% of AUM
8.07%
Top 10 Holdings %
Top 10 Hldgs %
9.53%
Holding
2,811
New
160
Increased
1,379
Reduced
1,053
Closed
105
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
$216M |
| 2 |
Vanguard Value ETF
VTV
|
$214M |
| 3 |
iShares MBS ETF
MBB
|
$210M |
| 4 |
WIN
Windstream Holdings Inc
WIN
|
$189M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
$188M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$155M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$103M |
| 3 |
MON
Monsanto Co
MON
|
$87.6M |
| 4 |
Oracle
ORCL
|
$82M |
| 5 |
Apple
AAPL
|
$76.4M |
Sector Composition
| 1 | Financials | 13.25% |
| 2 | Healthcare | 12.62% |
| 3 | Technology | 11.9% |
| 4 | Industrials | 9.5% |
| 5 | Consumer Discretionary | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
GE Aerospace
GE
$292B
| $469M | 0.52% | 18,300,838 +3,005,219 | +20% | +$77M |
|
27
Procter & Gamble
PG
$368B
| $460M | 0.51% | 5,495,450 +848,657 | +18% | +$71.1M |
|
|
28
iShares MBS ETF
MBB
$41B
| $455M | 0.51% | 4,208,171 +1,940,503 | +86% | +$210M |
|
29
Qualcomm
QCOM
$173B
| $453M | 0.51% | 6,062,757 +533,438 | +10% | +$39.9M |
|
|
CELG
30
DELISTED
Celgene Corp
CELG
| $452M | 0.5% | 4,765,895 -296,054 | -6% | -$28.1M |
|
31
Gilead Sciences
GILD
$140B
| $447M | 0.5% | 4,195,950 -499,014 | -11% | -$53.1M |
|
32
Vanguard Information Technology ETF
VGT
$99.7B
| $443M | 0.49% | 4,428,518 +1,720,565 | +64% | +$172M |
|
33
Exxon Mobil
XOM
$487B
| $420M | 0.47% | 4,462,883 +501,723 | +13% | +$47.2M |
|
34
Comcast
CMCSA
$125B
| $418M | 0.47% | 7,763,443 +1,659,351 | +27% | +$89.2M |
|
35
AT&T
T
$209B
| $417M | 0.47% | 11,845,906 +533,993 | +5% | +$18.8M |
|
36
General Dynamics
GD
$87.3B
| $410M | 0.46% | 3,227,014 +770,368 | +31% | +$97.9M |
|
|
37
iShares MSCI EAFE ETF
EFA
$66B
| $409M | 0.46% | 6,371,174 +2,925,029 | +85% | +$188M |
|
38
Lowe's Companies
LOW
$145B
| $407M | 0.45% | 7,699,354 -370,147 | -5% | -$19.6M |
|
39
Coca-Cola
KO
$297B
| $402M | 0.45% | 9,425,204 -267,927 | -3% | -$11.4M |
|
40
MetLife
MET
$54.1B
| $402M | 0.45% | 7,479,199 +357,199 | +5% | +$19.2M |
|
41
McDonald's
MCD
$224B
| $396M | 0.44% | 4,172,378 +1,009,228 | +32% | +$95.7M |
|
42
Eli Lilly
LLY
$657B
| $395M | 0.44% | 6,084,089 +880,857 | +17% | +$57.1M |
|
43
Vanguard Intermediate-Term Bond ETF
BIV
$24.1B
| $391M | 0.44% | 4,635,744 +2,141,776 | +86% | +$180M |
|
44
Union Pacific
UNP
$133B
| $382M | 0.43% | 3,523,163 -453,396 | -11% | -$49.2M |
|
45
Novartis
NVS
$245B
| $380M | 0.42% | 4,040,820 +80,548 | +2% | +$7.58M |
|
46
Home Depot
HD
$405B
| $372M | 0.41% | 4,049,765 -18,229 | -0.4% | -$1.67M |
|
47
Citigroup
C
$178B
| $371M | 0.41% | 7,149,832 +654,386 | +10% | +$33.9M |
|
48
Bristol-Myers Squibb
BMY
$96B
| $368M | 0.41% | 7,188,028 +81,799 | +1% | +$4.19M |
|
49
AbbVie
ABBV
$372B
| $360M | 0.4% | 6,233,031 +1,114,919 | +22% | +$64.4M |
|
50
Biogen
BIIB
$19.4B
| $358M | 0.4% | 1,082,983 +10,878 | +1% | +$3.6M |
|